Accuracy and precision in HER2/neu testing in breast cancer: are we there yet?

Yaziji, Hadi; Gown, Allen M

Yaziji, Hadi; Gown, Allen M.

Hum Pathol ; 35(2): 143-6, 2004 Feb.

Article in En | MEDLINE | ID: mdl-14991529

Subject(s)

Biomarkers, Tumor/analysis; Breast Neoplasms/chemistry; Breast Neoplasms/diagnosis; Immunohistochemistry; In Situ Hybridization, Fluorescence; Receptor, ErbB-2/analysis; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized; Antineoplastic Agents/therapeutic use; Breast Neoplasms/drug therapy; DNA, Neoplasm/analysis; Female; Gene Expression Regulation, Neoplastic; Humans; Predictive Value of Tests; RNA, Neoplasm/analysis; Receptor, ErbB-2/genetics; Sensitivity and Specificity; Trastuzumab; Treatment Outcome; Up-Regulation

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Immunohistochemistry / Biomarkers, Tumor / In Situ Hybridization, Fluorescence / Receptor, ErbB-2 Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans Language: En Journal: Hum Pathol Journal subject: PATOLOGIA Year: 2004 Type: Article

Search on Google

XML

PubMed Links